Maybe. Are we seeing any indication of increased success rates in stage 3 trials already for "AI drug candidates"?
Could also be that some things are not possible in some ways. I wonder if there is some general theory on "shortcuts".
Stage 1, yes, stage 2, it's a wash (for now at least), which does not promise much for stage 3, but it is still a bit early for that.